Clinical Trials Sponsored by Prima-Temp, Inc

Total 57 results

Prima-Temp, Inc

Unknown

Measuring Core Body Temperature Using TempuRing

Fertility

United States
Five Prime Therapeutics, Inc.

Completed

Study of Cabiralizumab in Patients With Pigmented Villonodular Synovitis / Diffuse Type Tenosynovial Giant Cell Tumor (FPA008-002)

Tenosynovial Giant Cell Tumor | Pigmented Villonodular Synovitis

United States, France, Netherlands, United Kingdom, Korea, Republic of, Poland
Main Line Health
Ananda Hemp, Inc.

Active, not recruiting

Effect of Hemp-CBD on Patients With CIPN (Coala-T-CBD)

Breast Cancer | Pancreatic Cancer | Ovarian Cancer | Colorectal Cancer Stage II | Colorectal Cancer Stage III | Chemotherapy-induced Peripheral Neuropathy | Uterine Cancer

United States
Five Prime Therapeutics, Inc.

Completed

FPT155 in Patients With Advanced Solid Tumors (FPT155-001)

Advanced Solid Tumors

Korea, Republic of, Australia
Five Prime Therapeutics, Inc.

Completed

A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 in Gastric/Gastroesophageal Cancer (FIGHT)

Gastric Cancer | Gastrointestinal Cancer | Gastrointestinal Cancer Metastatic

United States
Five Prime Therapeutics, Inc.

Completed

FPA150 in Patients With Advanced Solid Tumors (FPA150-001)

Breast Cancer | Ovarian Cancer | Advanced Solid Tumors | Endometrial Cancer

United States, Korea, Republic of
Five Prime Therapeutics, Inc.

No longer available

An Expanded Access Study of Bemarituzumab (FPA144) for a Single Patient With Recurrent Bladder Cancer (FPA144)

Recurrent Bladder Cancer
Five Prime Therapeutics, Inc.

Completed

Open-Label, Dose-Finding Study Evaluating Safety and PK of FPA144 in Patients With Advanced Solid Tumors

Gastric Cancer | Advanced Solid Tumors | Transitional Cell Carcinoma of the Bladder

Korea, Republic of, United States, Taiwan
Five Prime Therapeutics, Inc.

Terminated

Phase 1 Single and Multiple Dose Study of FPA008 in Healthy Volunteers and Rheumatoid Arthritis Subjects

Healthy | Rheumatoid Arthritis

Hungary, Netherlands, Poland
Prisma Health-Upstate
Xymogen, Inc.

Completed

Use of Probiotics to Aid in Weight Loss (Probiotics)

Weight Loss

United States
Prisma Health-Upstate
Oncolix, Inc.

Terminated

Trial of Melaxin Cancer Vaccine Plus Bacillus Calmette-Guerin (BCG) to Treat Malignant Melanoma

Melanoma

United States
Prisma Health-Upstate
Arthrex, Inc.

Enrolling by invitation

Lateralization After IntraMedullary Nailing of InterTrochanteric Hip Fractures, Clinical and Radiographic Outcomes (LIMIT)

Intertrochanteric Fractures

United States
Five Prime Therapeutics, Inc.
Parexel

Completed

Safety Study of FP-1039 To Treat Cancer

Advanced Cancer

United States
Five Prime Therapeutics, Inc.
Worldwide Clinical Trials

Withdrawn

Study of FP-1039 in Subjects With Endometrial Cancers

Endometrial Cancers With FGFR2 Mutations
Five Prime Therapeutics, Inc.
Bristol-Myers Squibb

Completed

Study of Cabiralizumab in Combination With Nivolumab in Patients With Selected Advanced Cancers (FPA008-003)

Renal Cell Carcinoma | Head and Neck Cancer | Pancreatic Cancer | Ovarian Cancer | Malignant Glioma | Advanced Solid Tumors | Non-small Cell Lung Cancer

United States
Eastern Virginia Medical School
Old Dominion University; Ananda Hemp, Inc.

Recruiting

Effects of THC-Free CBD Oil on Agitation in Patients With Alzheimer's Disease

Dementia | Alzheimer Disease | Major Neurocognitive Disorder With Aggressive Behavior

United States
Environment and Health Group, Inc.
Prisma Health

Completed

mHealth for ART Adherence by HIV+ African Americans

HIV-1-infection

United States
Primal Therapies Inc.
Benjamin Rose Institute on Aging

Unknown

Evaluation of a Daily Oral Care Lozenge on Oral Health and Quality of Life in Older Adults

Oral Health

United States
Five Prime Therapeutics, Inc.
Zai Lab (Shanghai) Co., Ltd.

Completed

A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 (mFOLFOX6) in Gastric/Gastroesophageal Junction Cancer (FIGHT)

Gastric Cancer

United States, Spain, China, Italy, Korea, Republic of, Portugal, Taiwan, Japan, Turkey, France, Hungary, Thailand, Germany, Poland, Australia, Belgium, Romania, United Kingdom
SafeMedWaste, Inc.
National Institute on Drug Abuse (NIDA); University of South Carolina; Prisma...

Not yet recruiting

SafeMedWaste At-Home, Environmentally-Friendly Opioid Disposal Kit for Orthopedic Post-Operative Surgical Patients to Reduce Opioids Available for Diversion (Drug Disposal)

Opioid Use Disorder
Prim. Prof. Dr. Oliver Findl, MBA

Recruiting

Rotation Stability of Toric Intraocularlens (IOL) Compared Sitting Against Lying After Cataract Operation

Astigmatism

Austria
Prim. Prof. Dr. Oliver Findl, MBA

Withdrawn

Performance of a Hydrophilic and a Hydrophobic Intraocular Lens of Similar Design

Cataract

Austria
Prim. Prof. Dr. Oliver Findl, MBA

Completed

Diurnal Changes of the Cornea - a Pilot Study

Astigmatism

Austria
Prim. Prof. Dr. Oliver Findl, MBA

Unknown

Perioperative Stress and Pain Perception of Second Eye Cataract Surgery

Cataract

Austria
Prim. Prof. Dr. Oliver Findl, MBA

Completed

Protecting the Corneal Endothelium During Cataract Surgery Using the Anterior Capsule

Endothelial Cell Loss, Corneal
Prim. Prof. Dr. Oliver Findl, MBA

Unknown

Prediction of Pseudophakodonesis of Intraocular Lenses

Cataract

Austria
Prim. Prof. Dr. Oliver Findl, MBA

Completed

Morphologic Changes After Membrane Peeling With Air Tamponade and Balanced Salt Solution

Epiretinal Membrane | Macular Pucker

Austria
Prim. Prof. Dr. Oliver Findl, MBA

Completed

Intraocular Lens Power Calculation Using Pre- and Intra-operative Measurements

Cataract

Austria
Prim. Prof. Dr. Oliver Findl, MBA

Unknown

A Study of the Beneficial Effects of Eplerenone on Central Serous Chorioretinopathy

Central Serous Chorioretinopathy

Austria
Prim. Prof. Dr. Oliver Findl, MBA

Completed

Intra-operative Measurements to Predict the Position of the Intraocular Lens Post-operatively

Cataracts
Wake Forest University Health Sciences
OrthoCarolina Research Institute, Inc.; Virginia Commonwealth University; Orthopaedic... and other collaborators

Terminated

Radiation Therapy for Heterotopic Ossification Prophylaxis Acutely After Elbow Trauma (ElbowHO)

Elbow Fracture
Prim. Prof. Dr. Oliver Findl, MBA

Recruiting

Intense Pulsed Light in Meibomian Gland Dysfunction

Meibomian Gland Dysfunction

Austria
Prim. Prof. Dr. Oliver Findl, MBA

Completed

Repeatability in Measurements of Two ssOCT and One OLCR Biometer

Cataract Senile

Austria
Prim. Prof. Dr. Oliver Findl, MBA

Unknown

LEC Proliferation in Vivo and In-vitro

Posterior Capsule Opacification

Austria
Prim. Prof. Dr. Oliver Findl, MBA

Unknown

Computer-based Tutorial for the Informed Consent Process for Cataract Surgery in Turkish or Serbian Speaking Patients

Cataract

Austria
Prim. Prof. Dr. Oliver Findl, MBA

Unknown

Comparison of a New EDOF-IOL With a Standard-EDOF-IOL

Cataract

Austria
Prim. Prof. Dr. Oliver Findl, MBA

Unknown

Reading Quality in Three Different Patient Groups

Pseudophakia

Austria
Prim. Prof. Dr. Oliver Findl, MBA

Unknown

Comparison of Stellaris Standard Infusion With Stellaris Elite

Cataract

Austria
Prim. Prof. Dr. Oliver Findl, MBA

Unknown

Comparing an Intraoperative vs. a Standard Wavefront Device

Cataract

Austria
Prim. Prof. Dr. Oliver Findl, MBA

Unknown

High Resolution Immersion Ultrasound for iIOL Power Calculation

Cataract

Austria
Prim. Prof. Dr. Oliver Findl, MBA

Completed

Impact of a Corneal Pre-cut on Wound Architecture and Astigmatism in Cataract Surgery - a Pilot Study

Cataract

Austria
Prim. Prof. Dr. Oliver Findl, MBA

Recruiting

Computer-based Tutorial and Automated Speech Recognition for Intravitreal Drug Injections

Age-related Macular Degeneration | Diabetic Macular Edema | Retinal Vein Occlusion

Austria
Prim. Prof. Dr. Oliver Findl, MBA

Unknown

Comparison of Wide-field Retinal Imaging

Retinal Disease

Austria
Prim. Prof. Dr. Oliver Findl, MBA

Unknown

Posterior Capsule Opacification After Lens Capsule Polishing

Posterior Capsule Opacification

Austria
Prim. Prof. Dr. Oliver Findl, MBA

Unknown

Assessing the Astigmatism Reducing Effect With Toric IOLs in Eyeswith Low Astigmatism (Low Asti)

Cataract | Astigmatism

Austria
Prim. Prof. Dr. Oliver Findl, MBA

Unknown

Anterior Chamber Depth Variability Between Two Lenses With Different Materials

Cataract

Austria
Prim. Prof. Dr. Oliver Findl, MBA

Unknown

Reading Analysis in Ophthalmologic Patients

Glaucoma | Age Related Macular Degeneration | Epiretinal Membrane | Diabetic Maculopathy

Austria
Prim. Prof. Dr. Oliver Findl, MBA

Unknown

Comparison of 2 Diffractive Trifocal IOLs

Cataract

Austria
Prim. Prof. Dr. Oliver Findl, MBA

Unknown

Low-add Multifocal vs. Monofocal IOLs

Cataract

Austria
Prim. Prof. Dr. Oliver Findl, MBA

Completed

Performance of a Single-piece Toric Acrylic Intraocular Lens

Cataract | Corneal Astigmatism

Clinical Trials Sponsored by Prima-Temp, Inc

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Belarus

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations